UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Psychological and pain effects of the use of the max mode of the Fotona Fidelis Er:YAG laser on patients, in Class I cavity preparations

Medicina oral, patología oral y cirugía bucal, 2012, p.S35-.

Tzannou, E.

2012

Link zum Volltext

Verfügbarkeit prüfen

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Science translational medicine, 2014-06, Vol.6 (242), p.242ra83

2014

Link zum Volltext

Verfügbarkeit prüfen

Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221107113

2022

Link zum Volltext

Verfügbarkeit prüfen

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

Clinical cancer research, 2023-01, Vol.29 (2), p.324-330

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Severe, Drug-Refractory Viral Infections with Allogeneic, Off-the-Shelf Multi-Virus Specific T Cells in Patients Following HSCT: Results from a Phase 2 Study

Blood, 2020-11, Vol.136 (Supplement 1), p.2-3

2020

Link zum Volltext

Verfügbarkeit prüfen

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects

Journal of clinical oncology, 2021-05, Vol.39 (13), p.1415-1425

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluating Cyclin A1 As an Immunotherapeutic Target in Acute Myeloid Leukemia (AML)

Blood, 2017-12, Vol.130, p.1907-1907

2017

Link zum Volltext

Verfügbarkeit prüfen

PB2140: ALLOGENEIC STEM CELL TRANSPLANTATION IN RARE T‐NHL SUBTYPES: FOCUS ON AITL, MF/SS, HSTCL. A SINGLE BMT‐UNIT EXPERIENCE

HemaSphere, 2022-06, Vol.6 (Suppl), p.2011-2012

2022

Link zum Volltext

Verfügbarkeit prüfen

Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL

Blood, 2021-11, Vol.138 (Supplement 1), p.471-471

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting Lymphomas Using Non-Engineered, Multi-Antigen Specific T Cells

Blood, 2018-11, Vol.132 (Supplement 1), p.1685-1685

2018

Link zum Volltext

Verfügbarkeit prüfen

Adoptive T-Cell Therapy for Acute Lymphoblastic Leukemia Targeting Multiple Tumor Associated Antigens

Blood, 2018-11, Vol.132 (Supplement 1), p.2693-2693

2018

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Adoptively Transferred Donor-Derived Tumor-Directed T Cells with Relapsed AML Post-Allogeneic HSCT

Blood, 2017-12, Vol.130, p.164-164

2017

Link zum Volltext

Verfügbarkeit prüfen

“Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients

Blood advances, 2019-09, Vol.3 (17), p.2571-2580

2019

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic, Off-the-Shelf Multi-Virus Specific T-Lymphocytes for the Treatment of Virus-Associated Hemorrhagic Cystitis in the Post-HSCT Setting

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.S91-S92

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy for Lymphoma Using T Cells Targeting Multiple Tumor Associated Antigens

Blood, 2015-12, Vol.126 (23), p.186-186

2015

Link zum Volltext

Verfügbarkeit prüfen

Adoptively-Transferred EBV-Specific T Cells to Prevent or Treat EBV-Related Lymphoproliferative Disease in Allogeneic HSCT Recipients - a Single Center Experience Spanning 22 Years

Blood, 2015-12, Vol.126 (23), p.1926-1926

2015

Link zum Volltext

Verfügbarkeit prüfen

Administration of Most Closely HLA-Matched Multivirus-Specific T Cells for the Treatment of EBV, CMV, AdV, HHV6, and BKV Post Allogeneic Hematopoietic Stem Cell Transplant

Blood, 2015-12, Vol.126 (23), p.622-622

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract IA22: Immunotherapy with virus-specific T cells

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.IA22-IA22

2016

Link zum Volltext

Verfügbarkeit prüfen

25 - Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S24-S24

2022

Link zum Volltext

Verfügbarkeit prüfen

Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S24

2022

Link zum Volltext

Verfügbarkeit prüfen

Skin Cancer in the Elderly

In vivo (Athens), 2005-05, Vol.19 (3), p.643-652

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Psychological and pain effects of the use of the max mode of the Fotona Fidelis Er:YAG laser on patients, in Class I cavity preparations

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL

Treatment of Severe, Drug-Refractory Viral Infections with Allogeneic, Off-the-Shelf Multi-Virus Specific T Cells in Patients Following HSCT: Results from a Phase 2 Study

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects

Evaluating Cyclin A1 As an Immunotherapeutic Target in Acute Myeloid Leukemia (AML)

PB2140: ALLOGENEIC STEM CELL TRANSPLANTATION IN RARE T‐NHL SUBTYPES: FOCUS ON AITL, MF/SS, HSTCL. A SINGLE BMT‐UNIT EXPERIENCE

Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL

Targeting Lymphomas Using Non-Engineered, Multi-Antigen Specific T Cells

Adoptive T-Cell Therapy for Acute Lymphoblastic Leukemia Targeting Multiple Tumor Associated Antigens

Safety and Efficacy of Adoptively Transferred Donor-Derived Tumor-Directed T Cells with Relapsed AML Post-Allogeneic HSCT

“Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients

Allogeneic, Off-the-Shelf Multi-Virus Specific T-Lymphocytes for the Treatment of Virus-Associated Hemorrhagic Cystitis in the Post-HSCT Setting

Adoptive Immunotherapy with Rapidly-Generated Multivirus-Specific T Cells Against AdV, EBV, CMV, HHV6 and BK after Allogeneic Hematopoietic Stem Cell Transplant

Immunotherapy for Lymphoma Using T Cells Targeting Multiple Tumor Associated Antigens

Adoptively-Transferred EBV-Specific T Cells to Prevent or Treat EBV-Related Lymphoproliferative Disease in Allogeneic HSCT Recipients - a Single Center Experience Spanning 22 Years

Administration of Most Closely HLA-Matched Multivirus-Specific T Cells for the Treatment of EBV, CMV, AdV, HHV6, and BKV Post Allogeneic Hematopoietic Stem Cell Transplant

Administration of Most Closely HLA-Matched Multivirus-Specific T Cells for the Treatment of EBV, CMV, AdV, HHV6, and BKV Post Allogeneic Hematopoietic Stem Cell Transplant

Abstract IA22: Immunotherapy with virus-specific T cells

25 - Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL

Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL

Skin Cancer in the Elderly

Suchergebnisse filtern